Loading chat...
GA HB1352
Bill
Status
Introduced
2/21/2024
Primary Sponsor
Lydia Glaize
Click for details
AI Summary
- Prescribers must discuss specific risk information with patients (or parents/guardians of minors) before issuing the first and third prescriptions for a Schedule II controlled substance or opioid in a course of treatment, including the risks of addiction, physical or psychological dependence, and fatal respiratory depression from overdose or mixing with alcohol, benzodiazepines, or other CNS depressants
- Prescribers must also explain why the prescription is necessary, what alternative treatment options are available, and the risks and benefits of those alternatives
- Prescribers must make reasonable efforts to confirm the patient or guardian understands the information provided and must document the discussion in the patient's medical record
- Exemptions apply for patients receiving cancer treatment, palliative care, or hospice care, residents of long-term care facilities, and prescriptions for substance abuse or opioid dependence treatment
- Amends Article 5 of Chapter 4 of Title 26 of the Official Code of Georgia Annotated by adding new Code Section 26-4-91
Legislative Description
Pharmacists; prescribers provide certain information to patients or their representatives on Schedule II controlled substances or opioids
Last Action
House Second Readers
2/26/2024
Committee Referrals
Health2/22/2024
Full Bill Text
No bill text available